ClinConnect ClinConnect Logo
Search / Trial NCT04678167

Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis

Launched by UNIVERSITY HOSPITAL, BREST · Dec 16, 2020

Trial Information

Current as of August 21, 2025

Recruiting

Keywords

Vestibular Hyporeflexia Rotational Vertigo Horizontal Rotational Nystagmus

ClinConnect Summary

This clinical trial is investigating whether wearing special Boarding Ring glasses can help patients with vestibular neuritis recover more quickly from their symptoms. Vestibular neuritis is a condition that causes severe dizziness, a spinning sensation, and sometimes nausea, but it does not affect hearing. The study aims to see if these glasses can assist the body in adjusting and compensating for the balance issues caused by the condition.

To participate in this trial, you need to be an adult aged 65 to 74 who is experiencing continuous dizziness and has certain eye movements that indicate vestibular neuritis. You should not have a history of other types of vertigo, hearing loss, or certain eye movement disorders. If you join the study, you can expect to wear the glasses during the trial period and be monitored for changes in your symptoms. This research could be important for finding better treatments for dizziness related to vestibular neuritis.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adult patients,
  • patient with vestibular neuritis defined by appearance of continuous rotating vertigo with nausea
  • patient with spontaneous horizonto-rotating nystagmus beating towards the healthy ear
  • patient with a postural deviation towards the affected ear;
  • vestibular hyporeflexia measured at the caloric tests greater than 25%
  • patient who has given free, enlighten and written consent
  • Exclusion Criteria:
  • patient with a history of vertigo of vestibular origin or with vertigo developing for more than 4 days
  • patient with associated hearing loss or tinnitus
  • patient with an motor ocular abnormality of central origin
  • patient refusal or inability to consent

About University Hospital, Brest

The University Hospital of Brest is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. With a strong emphasis on interdisciplinary collaboration, the hospital serves as a hub for cutting-edge clinical trials aimed at improving treatment outcomes across various medical specialties. Leveraging its robust academic affiliations and state-of-the-art facilities, the University Hospital of Brest is committed to fostering scientific discovery and enhancing the quality of life for patients through evidence-based practices and pioneering research initiatives.

Locations

Brest, , France

Quimper, , France

Morlaix, , France

Patients applied

0 patients applied

Trial Officials

Jean-Christophe LECLERE, Dr

Principal Investigator

University Hospital, Brest

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials